Profit from Panic: 3 Top Contrarian Stocks to Buy Now

Hunting for a bargain? This group of beaten-down stocks, including Bausch Health Companies (TSX:BHC)(NYSE:BHC), might provide the value you’re looking for.

| More on:

Hi there, Fools. I’m back to highlight three stocks that fell sharply last week. As a quick reminder, I do this because great wealth is built by buying quality companies: during periods of extreme pessimism; when professional analysts are turning away from them; and when they’re available at a discount to intrinsic value.

As the great Warren Buffett once warned, “You pay a very high price in the stock market for a cheery consensus.”

So, without further ado, let’s get to it.

Car wreck

Leading off our list is auto parts company Uni-Select (TSX:UNS), whose shares plunged a whopping 35% last week.

Most of the damage was done on Wednesday, when the company posted disappointing Q4 results. During the quarter, adjusted EPS and EBITDA came in well below expectations on revenue growth of just 1%. Moreover, the company’s 2019 guidance — organic sales growth of 1.25%-3.25% and EBITDA margin of 5.75%-6.75% — also missed estimates.

Management is continuing with a strategic review to address its ongoing challenges. Uni-Select also has a leveraged balance sheet, so the stock isn’t for the fainthearted.

That said, with the shares now off 50% from their 52-week highs and trading at a cheapish forward P/E of 11, now might be a good time for enterprising investors to take a look.

Real estate slump

Next up we have real estate services company Altus Group (TSX:AIF), which is down 7% over the past week.

The big drop came on Friday after the company’s weaker-than-expected Q4 results: earnings fell 13% to $55 million as revenue improved just 6%. Adjusted operating margin also declined significantly on reinvestments, thereby suggesting that Altus’ competitive edge is becoming more expensive to maintain.

That said, management remains bullish.

Altus CEO Robert Courteau said, “2018 was a very productive year as we further expanded our Altus Analytics business into Europe and Asia, added sales to larger, enterprise deals with a higher mix of recurring revenues, and increased the market share of our Property Tax business.”

After the pullback, Altus shares are off 27% from their 52-week highs and offer a decent yield of 2.5%.

Healthy value

Rounding out our list is pharmaceutical company Bausch Health Companies (TSX:BHC)(NYSE:BHC), whose shares sank 8% last week.

Bay Street wasn’t thrilled with Bausch’s Q4 results. During the quarter, the company posted a loss of $350 million as revenue declined 1.9% to $2.12 billion. Bausch’s full-year 2019 guidance — non-GAAP EBITDA of $3.35-$3.5 billion on revenue of $8.3-$8.5 billion — also failed to impress investors.

On the (very) bright side, Bausch’s organic revenue continues to grow steadily while its debt load continues to decline, suggesting that management’s turnaround efforts are progressing nicely.

“2018 was a strong year for Bausch Health as we delivered organic revenue growth across the entire Company while reducing our total debt by more than $1 billion and strategically investing in our core businesses,” said Chairman and CEO Joseph Papa.

Bausch shares are now off about 15% from their 52-week highs.

The bottom line

There you have it, Fools: three slumping stocks worth checking out.

As always, they aren’t formal recommendations. Just view them as a starting point for further research. Plunging stocks can keep plunging for a prolonged period of time, so plenty of your own homework is required.

Fool on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of Bausch Health Companies.

More on Investing

A worker drinks out of a mug in an office.
Investing

Here’s the Average TFSA Balance at Age 34 in Canada

Have you ever wondered how your TFSA stacks up compared to the average Canadian?

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

A Dividend Giant I’d Buy Over BCE Stock Right Now

Don't get sucked in by BCE's 10% dividend -- the stock is a total yield trap. Buy this instead.

Read more »

Female raising hands enjoying vacation, standing on background of blue cloudless sky.
Dividend Stocks

Best Beginner-Friendly Stocks to Buy Now in Canada

These top TSX stocks have delivered attractive long-term returns.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

Consider Sienna Senior Living for a Stable Monthly Income

Buying this Canadian dividend stock could help you build a dependable monthly income portfolio for the long term.

Read more »

Pumpjack in Alberta Canada
Energy Stocks

Where Will Imperial Oil Stock Be in 1 Year?

Imperial Oil is a TSX energy stock that has delivered market-thumping returns to shareholders over the last two decades.

Read more »

Investing

Got $1,000? 3 Top Canadian Stocks to Buy Right Now

These three Canadian stocks are ideal additions to your portfolios.

Read more »

customer uses bank ATM
Dividend Stocks

Here’s the Average TFSA and RRSP at Age 65 for Canadians

The TFSA and RRSP together make an ideal pairing for retirees, but is the average even enough?

Read more »

nvidia headquarters with nvidia sign in front
Tech Stocks

Nvidia Just Delivered a Beat-and-Raise Quarter. There’s 1 Red Flag Investors Shouldn’t Ignore.

The chipmaker continued to benefit from robust demand for artificial intelligence (AI). But can it last?

Read more »